MedTrace Logo

The Safety of Vardenafil in Patients Undergoing Cardiac Surgery

NCT01260285 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2011-11-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety of vardenafil in cardiac surgery patients.

Conditions

  • Ischemia-reperfusion Injury.

Interventions

DRUG

Vardenafil

10 mg PO once

Sponsors & Collaborators

  • McGuire Research Institute

    lead OTHER

Principal Investigators

  • Ion Jovin, MD · McGuire VAMC

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01260285 on ClinicalTrials.gov